Skip to main content Start main content

Research Subject Recruitment

Topic Target Recruitment Status
Improving Vision in Patients with Macular Degeneration

Principal Investigator

Dr Allen Cheong

Enquiry

WhatsApp / Tel.: 5122 7266 (Ms Lyu)

    • Aged over 18
    • Both eyes are diagnosed with macular degeneration
    • Able to read traditional Chinese
    • No other eye diseases, no brain diseases (e.g. stroke, Parkinson’s disease), heart disease, brain surgery, epilepsy, neurological disorders, cognitive impairment (e.g. dementia), no metal implants (except fillings)
    • No adverse reactions to brain stimulation
Recruitment in progress.
PROgressive Myopia Treatment Evaluation for NaturalVue Multifocal Contact Lens Trial (PROTECT)

Principal Investigator

Dr. TSE Yan Yin Dennis

Enquiry

Email: myopia.protect@polyu.edu.hk
Tel.: 9423 7164


Registration (in Chinese)
https://bit.ly/3kJQ11x

    • Children aged between 7 -12 years
    • Myopia between -0.75 D to -5.00 D
    • Astigmatism: not more than -1.00 D
    • Refractive error between eyes: not more than -1.00 D
    • Good general health and no ocular diseases
    • No history on myopia control such as atropine, orthokeratology, or myopic control contact lenses and spectacle lenses
    • Has not worn or currently wears rigid or gas permeable contact lenses
    • Agree to wear contact lenses for a minimum of 10 hours per day
Recruitment in progress.
Improving vision and quality of life in patients with glaucoma using non-invasive brain stimulation and perceptual learning A Randomized Clinical Trial

Principal Investigator

Dr Allen Cheong

Enquiry

Ms Tong / Ms Suen
Tel./ WhatsApp: 5910 0087 / 9734 2120
Email: soglauco@polyu.edu.hk

 

Registration (in Chinese):

https://hkvisionrehab.org/application-form/

 

Project website (in Chinese): https://hkvisionrehab.org/

    • Aged 18-80
    • Both eyes are diagnosed as glaucoma
    • No other eye diseases, no brain diseases (e.g. stroke, Parkinson’s disease, heart disease, brain surgery, epilepsy, neurological disorders, cognitive impairment (e.g. dementia), no metal implants (except fillings) or any hearing problems
    • Vision have remained stable in the last 3 months
    • No adverse reactions to Transcranial Electrical Stimulation (tES)
Recruitment in progress.
Effectiveness of bright light therapy, myopic defocus and the combinations for controlling myopic eye growth in schoolchildren: A randomized control trial

Principal Investigator
Prof. To Chi-ho

Enquiry
Email: rif.adm@polyu.edu.hk
Registration: https://bit.ly/3h8gLr1

    • Children aged between 7 -12 years
    • Myopia between -0.75D to -5.00 D
    • Astigmatism: less than ≤ -1.50 D
    • No history on myopia control such as atropine, orthokeratology, or myopic control contact lenses and spectacle lenses
    • No squint (crossed eye) or amblyopia (lazy eye)
Recruitment in progress. Spaces are limited and available on a first-come-first-served basis.
Anterior Eye Assessment

Principal Investigator
Dr Thomas Lam

Enquiry
WhatsApp: 5725 7392
Email: cevr.dryeye@polyu.edu.hk
Registration: https://bit.ly/3lYXpId

  • Age 13 years old or above (parental consent is required for participants aged under 18 years old)
  • Lived in Hong Kong for at least 3 years
Recruitment in progress. Spaces are limited and available on a first-come-first-served basis.
Oculomotor deficits in Parkinson’s Disease

Principal Investigator
Dr Allen Cheong

Enquiry
Ms Tsang
Tel.: 3400 2913/ 6103 5944
Email: lltsang@polyu.edu.hk

    People with or without Parkinson’s disease are all welcome:

    • Aged 40-70
    • Good vision
    • Able to speak and comprehend Chinese (Cantonese)
    • No squint or lazy eye
    • No known eye diseases
    • No medical problems, e.g. stoke, etc.
    • No medical surgery: e.g. heart surgery, brain surgery, etc.
    • No cognitive impairments, e.g. dementia, etc.
Spaces are limited and available on a first-come-first-served basis

Your browser is not the latest version. If you continue to browse our website, Some pages may not function properly.

You are recommended to upgrade to a newer version or switch to a different browser. A list of the web browsers that we support can be found here